Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

Keyphrases

• Lung Adenocarcinoma 100%
• Monoclonal Antibody 100%
• Fibroblast Growth Factor Receptor 3 (FGFR3) 100%
• FGF9 40%
• Mouse Model 30%
• Human Cancer 20%
• Congenital Disorders 10%
• Ligand-binding Domain 10%
• High-affinity Ligands 10%
• Tumorigenesis 10%
• Human Lung Cancer 10%
• Epithelial Ingrowth 10%
• Personalized Therapy 10%
• Lung Epithelial Cells 10%
• Activating mutation 10%
• Resectable Lung Cancer 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Adenocarcinoma 100%
• Human Monoclonal Antibody 100%
• Fibroblast Growth Factor Receptor 3 100%
• Fibroblast Growth Factor 9 40%
• Mouse Model 30%
• Receptor 10%
• Malignant Neoplasm 10%
• Carcinogenesis 10%
• Non Small Cell Lung Cancer 10%
• Lung Cancer 10%
• Congenital Malformation 10%